WPD Pharmaceuticals Inc (WBIO)

[Renee]

WPD Pharmaceuticals Inc.: "On May 12, 2020, WPD and Mariusz Olejniczak, WPD’s CEO, filed a petition to terminate the trading suspension. In accordance with Rule of Practice 550(b), additional written submissions are requested."

Accordingly, IT IS ORDERED that the parties file submissions as follows:

By May 21, 2020, the Division of Enforcement shall file all the
information that was before the Commission at the time of the Trading
Suspension Order’s issuance.

By June 4, 2020, petitioners shall file an opening brief, which is not to exceed 8,000 words.

By June 18, 2020, the Division shall file an answering brief, which is
not to exceed 8,000 words.

By July 2, 2020, petitioners may file an optional reply brief, which is not to exceed 3,000 words.


https://www.sec.gov/litigation/opinions/2020/34-88871.pdf